Both in Pharmaceuticals
Keros Therapeutics vs Eledon Pharmaceuticals
Over the past year KROS returned −26.5% and ELDN returned −36.3%; their daily moves had a correlation of 0.13.
KROS −26.5% ELDN −36.3%Growth of $1, one year, split-adjusted
| Metric | KROS | ELDN |
|---|---|---|
| Price | $11.04 | $2.77 |
| Market cap | $218.9M | $225.1M |
| Today | −2.82% | −8.88% |
| 1 month | −2.0% | +13.8% |
| 6 months | −3.9% | −24.9% |
| Year to date | −45.8% | +83.4% |
| 1 year | −26.6% | −34.8% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 14.6× | — |
| Net cash | $257.6M | $88.8M |
| Dividend yield | — | — |
| Volatility (60d) | 44.7% | 62.1% |
| Short % of float | 6.2% | 9.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).